{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:43:47Z","timestamp":1765547027976},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T00:00:00Z","timestamp":1677283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T00:00:00Z","timestamp":1677283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Guillain-Barr\u00e9 syndrome (GBS) is an immune-mediated inflammatory polyradiculoneuropathy, which commonly leads to a very high level of neurological disability. Especially, after the global outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the causation between GBS and SARS-CoV-2 infection and the coronavirus disease 2019 (COVID-19) vaccination have aroused widespread concern. In the review, we analyzed the impacts of SARS-CoV-2 infection and COVID-19 vaccination on GBS globally, aiming to further understand the characteristics of GBS associated with COVID-19. Based on the electrophysiological data, patients suffering from GBS related to COVID-19 manifested as an acute inflammatory demyelinating polyneuropathy (AIDP). Moreover, we summarized the current findings, which may evidence GBS linking to SARS-CoV-2 infection and COVID-19 vaccination, and discussed the underlying mechanisms whether and how the SARS-CoV-2 virus and COVID-19 vaccination can induce GBS and its variants.\n<\/jats:p>","DOI":"10.1186\/s40001-023-01055-0","type":"journal-article","created":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T08:02:44Z","timestamp":1677312164000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Is there a causal nexus between COVID-19 infection, COVID-19 vaccination, and Guillain-Barr\u00e9 syndrome?"],"prefix":"10.1186","volume":"28","author":[{"given":"Xiaoxiao","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanna","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kangding","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiujuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,25]]},"reference":[{"issue":"2","key":"1055_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000324710","volume":"36","author":"JJ Sejvar","year":"2011","unstructured":"Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain-Barre syndrome: a systematic review and meta-analysis. Neuroepidemiology. 2011;36(2):123\u201333.","journal-title":"Neuroepidemiology"},{"issue":"10045","key":"1055_CR2","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","volume":"388","author":"HJ Willison","year":"2016","unstructured":"Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barr\u00e9 syndrome. Lancet. 2016;388(10045):717\u201327.","journal-title":"Lancet"},{"issue":"5","key":"1055_CR3","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1055\/s-0039-1693005","volume":"39","author":"E Malek","year":"2019","unstructured":"Malek E, Salameh J. Guillain-Barre Syndrome. Semin Neurol. 2019;39(5):589\u201395.","journal-title":"Semin Neurol"},{"issue":"8","key":"1055_CR4","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3390\/medicina57080775","volume":"57","author":"T Chmiela","year":"2021","unstructured":"Chmiela T, Rzepka M, Krzystanek E, Gorzkowska A. A 50-year-old patient with guillain-barre syndrome after COVID-19: a case report. Medicina (Kaunas). 2021;57(8):775.","journal-title":"Medicina (Kaunas)"},{"issue":"1","key":"1055_CR5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.autrev.2016.09.022","volume":"16","author":"S Esposito","year":"2017","unstructured":"Esposito S, Longo MR. Guillain-Barre syndrome. Autoimmun Rev. 2017;16(1):96\u2013101.","journal-title":"Autoimmun Rev"},{"issue":"4","key":"1055_CR6","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s00415-020-09911-3","volume":"268","author":"GL Gigli","year":"2021","unstructured":"Gigli GL, Bax F, Marini A, Pellitteri G, Scalise A, Surcinelli A, et al. Guillain-Barre syndrome in the COVID-19 era: just an occasional cluster? J Neurol. 2021;268(4):1195\u20137.","journal-title":"J Neurol"},{"issue":"7","key":"1055_CR7","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1136\/jnnp-2020-324837","volume":"92","author":"M Filosto","year":"2021","unstructured":"Filosto M, Cotti Piccinelli S, Gazzina S, Foresti C, Frigeni B, Servalli MC, et al. Guillain-Barr\u00e9 syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions. J Neurol Neurosurg Psychiatry. 2021;92(7):751\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"1055_CR8","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/ana.25987","volume":"89","author":"M Fragiel","year":"2021","unstructured":"Fragiel M, Mir\u00f3 \u00d2, Llorens P, Jim\u00e9nez S, Pi\u00f1era P, Burillo G, et al. Incidence, clinical, risk factors and outcomes of Guillain-Barr\u00e9 in Covid-19. Ann Neurol. 2021;89(3):598\u2013603.","journal-title":"Ann Neurol"},{"issue":"6585","key":"1055_CR9","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1126\/science.abm8108","volume":"375","author":"M Merad","year":"2022","unstructured":"Merad M, Blish CA, Sallusto F, Iwasaki A. The immunology and immunopathology of COVID-19. Science. 2022;375(6585):1122\u20137.","journal-title":"Science"},{"issue":"3","key":"1055_CR10","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.cmi.2020.11.005","volume":"27","author":"E Meppiel","year":"2021","unstructured":"Meppiel E, Peiffer-Smadja N, Maury A, Bekri I, Delorme C, Desestret V, et al. Neurologic manifestations associated with COVID-19: a multicentre registry. Clin Microbiol Infect. 2021;27(3):458\u201366.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"1055_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11910-021-01102-5","volume":"21","author":"S Andalib","year":"2021","unstructured":"Andalib S, Biller J, Di Napoli M, Moghimi N, McCullough LD, Rubinos CA, et al. Peripheral nervous system manifestations associated with COVID-19. Curr Neurol Neurosci Rep. 2021;21(3):9.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"10","key":"1055_CR12","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1136\/jnnp-2020-324491","volume":"91","author":"A Uncini","year":"2020","unstructured":"Uncini A, Vallat J-M, Jacobs BC. Guillain-Barr\u00e9 syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic. J Neurol Neurosurg Psychiatry. 2020;91(10):1105\u201310.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"1055_CR13","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1093\/brain\/awaa433","volume":"144","author":"S Keddie","year":"2021","unstructured":"Keddie S, Pakpoor J, Mousele C, Pipis M, Machado PM, Foster M, et al. Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barre syndrome. Brain. 2021;144(2):682\u201393.","journal-title":"Brain"},{"issue":"10","key":"1055_CR14","doi-asserted-by":"publisher","first-page":"3517","DOI":"10.1111\/ene.14860","volume":"28","author":"L Palaiodimou","year":"2021","unstructured":"Palaiodimou L, Stefanou MI, Katsanos AH, Fragkou PC, Papadopoulou M, Moschovos C, et al. Prevalence, clinical characteristics and outcomes of Guillain-Barre syndrome spectrum associated with COVID-19: A systematic review and meta-analysis. Eur J Neurol. 2021;28(10):3517\u201329.","journal-title":"Eur J Neurol"},{"issue":"4","key":"1055_CR15","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s00415-020-10124-x","volume":"268","author":"S Abu-Rumeileh","year":"2021","unstructured":"Abu-Rumeileh S, Abdelhak A, Foschi M, Tumani H, Otto M. Guillain-Barre syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases. J Neurol. 2021;268(4):1133\u201370.","journal-title":"J Neurol"},{"issue":"1","key":"1055_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s41983-021-00310-7","volume":"57","author":"J Finsterer","year":"2021","unstructured":"Finsterer J, Scorza FA. Guillain-Barre syndrome in 220 patients with COVID-19. Egypt J Neurol Psychiatr Neurosurg. 2021;57(1):55.","journal-title":"Egypt J Neurol Psychiatr Neurosurg"},{"issue":"6","key":"1055_CR17","first-page":"203","volume":"72","author":"P Zuberb\u00fchler","year":"2021","unstructured":"Zuberb\u00fchler P, Conti ME, Le\u00f3n-Cejas L, Maximiliano-Gonz\u00e1lez F, Bonardo P, Miquelini A, et al. Guillain-Barre syndrome associated to COVID-19 infection: a review of published case reports. Rev Neurol. 2021;72(6):203\u201312.","journal-title":"Rev Neurol"},{"key":"1055_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/milmed\/usab158","author":"AC Yiu","year":"2021","unstructured":"Yiu AC, Hussain A, Okonkwo UA, Villacorta-Lyew R, McMahon MJ, Blattner M. Guillain-Barre syndrome associated with COVID-19 pneumonia-the first documented case in a U.S. military intensive care unit. Mil Med. 2021. https:\/\/doi.org\/10.1093\/milmed\/usab158.","journal-title":"Mil Med"},{"issue":"5","key":"1055_CR19","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S1474-4422(20)30109-5","volume":"19","author":"H Zhao","year":"2020","unstructured":"Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection: causality or coincidence? The Lancet Neurology. 2020;19(5):383\u20134.","journal-title":"The Lancet Neurology"},{"issue":"5","key":"1055_CR20","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/WCO.0000000000000602","volume":"31","author":"AY Doets","year":"2018","unstructured":"Doets AY, Jacobs BC, van Doorn PA. Advances in management of Guillain-Barre syndrome. Curr Opin Neurol. 2018;31(5):541\u201350.","journal-title":"Curr Opin Neurol"},{"issue":"10","key":"1055_CR21","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1093\/brain\/awy232","volume":"141","author":"AY Doets","year":"2018","unstructured":"Doets AY, Verboon C, van den Berg B, Harbo T, Cornblath DR, Willison HJ, et al. Regional variation of Guillain-Barr\u00e9 syndrome. Brain. 2018;141(10):2866\u201377.","journal-title":"Brain"},{"issue":"21","key":"1055_CR22","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1212\/WNL.0000000000010817","volume":"95","author":"G Liberatore","year":"2020","unstructured":"Liberatore G, De Santis T, Doneddu PE, Gentile F, Albanese A, Nobile-Orazio E. Clinical reasoning: a case of COVID-19-associated pharyngeal-cervical-brachial variant of Guillain-Barre syndrome. Neurology. 2020;95(21):978\u201383.","journal-title":"Neurology"},{"issue":"4","key":"1055_CR23","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1007\/s13365-021-00997-7","volume":"27","author":"E Biassoni","year":"2021","unstructured":"Biassoni E, Assini A, Gandoglia I, Benedetti L, Boni S, Pontali E, et al. The importance of thinking about Guillain-Barr\u00e9 syndrome during the COVID-19 pandemic: a case with pure dysautonomic presentation. J Neurovirol. 2021;27(4):662\u20135.","journal-title":"J Neurovirol"},{"issue":"26","key":"1055_CR24","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1056\/NEJMc2009191","volume":"382","author":"G Toscano","year":"2020","unstructured":"Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG, et al. Guillain-Barr\u00e9 Syndrome associated with SARS-CoV-2. N Engl J Med. 2020;382(26):2574\u20136.","journal-title":"N Engl J Med"},{"issue":"11","key":"1055_CR25","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1111\/ene.14462","volume":"27","author":"P De Sanctis","year":"2020","unstructured":"De Sanctis P, Doneddu PE, Vigano L, Selmi C, Nobile-Orazio E. Guillain-Barre syndrome associated with SARS-CoV-2 infection. A systematic review. Eur J Neurol. 2020;27(11):2361\u201370.","journal-title":"Eur J Neurol"},{"issue":"4","key":"1055_CR26","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1007\/s00415-020-10005-3","volume":"268","author":"L Tatu","year":"2021","unstructured":"Tatu L, Nono S, Gracio S, Kocer S. Guillain-Barre syndrome in the COVID-19 era: another occasional cluster? J Neurol. 2021;268(4):1198\u2013200.","journal-title":"J Neurol"},{"issue":"1","key":"1055_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s40120-020-00225-0","volume":"10","author":"J Losy","year":"2021","unstructured":"Losy J. SARS-CoV-2 infection: symptoms of the nervous system and implications for therapy in neurological disorders. Neurol Ther. 2021;10(1):31\u201342.","journal-title":"Neurol Ther"},{"issue":"5","key":"1055_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awab069","volume":"144","author":"M Foschi","year":"2021","unstructured":"Foschi M, D\u2019Anna L, Abdelhak A, Mayer B, Tumani H, Otto M, et al. Ongoing challenges in unravelling the association between COVID-19 and Guillain-Barre syndrome. Brain. 2021;144(5): e44.","journal-title":"Brain"},{"issue":"12","key":"1055_CR29","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrneurol.2016.172","volume":"12","author":"JA Goodfellow","year":"2016","unstructured":"Goodfellow JA, Willison HJ. Guillain-Barre syndrome: a century of progress. Nat Rev Neurol. 2016;12(12):723\u201331.","journal-title":"Nat Rev Neurol"},{"issue":"12","key":"1055_CR30","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1136\/jnnp-2020-324279","volume":"91","author":"C Civardi","year":"2020","unstructured":"Civardi C, Collini A, Geda DJ, Geda C. Antiganglioside antibodies in Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection. J Neurol Neurosurg Psychiatry. 2020;91(12):1361\u20132.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"1055_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105960","volume":"55","author":"J Fantini","year":"2020","unstructured":"Fantini J, Di Scala C, Chahinian H, Yahi N. Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection. Int J Antimicrob Agents. 2020;55(5): 105960.","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"1055_CR32","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.cytogfr.2013.05.005","volume":"24","author":"HL Zhang","year":"2013","unstructured":"Zhang HL, Zheng XY, Zhu J. Th1\/Th2\/Th17\/Treg cytokines in Guillain-Barre syndrome and experimental autoimmune neuritis. Cytokine Growth Factor Rev. 2013;24(5):443\u201353.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"5","key":"1055_CR33","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/j.1365-2990.2009.01016.x","volume":"35","author":"ZY Zhang","year":"2009","unstructured":"Zhang ZY, Zhang Z, Schluesener HJ. FTY720 attenuates lesional interleukin-17(+) cell accumulation in rat experimental autoimmune neuritis. Neuropathol Appl Neurobiol. 2009;35(5):487\u201395.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1055_CR34","doi-asserted-by":"publisher","first-page":"8489251","DOI":"10.1155\/2016\/8489251","volume":"2016","author":"X Fan","year":"2016","unstructured":"Fan X, Zhang H, Cheng Y, Jiang X, Zhu J, Jin T. Double roles of macrophages in human neuroimmune diseases and their animal models. Mediators Inflamm. 2016;2016:8489251.","journal-title":"Mediators Inflamm"},{"issue":"5","key":"1055_CR35","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13024","volume":"54","author":"Z Li","year":"2021","unstructured":"Li Z, Huang Z, Li X, Huang C, Shen J, Li S, et al. Bioinformatic analyses hinted at augmented T helper 17 cell differentiation and cytokine response as the central mechanism of COVID-19-associated Guillain-Barre syndrome. Cell Prolif. 2021;54(5): e13024.","journal-title":"Cell Prolif"},{"issue":"12","key":"1055_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102681","volume":"19","author":"FS Hussain","year":"2020","unstructured":"Hussain FS, Eldeeb MA, Blackmore D, Siddiqi ZA. Guillain Barre syndrome and COVID-19: possible role of the cytokine storm. Autoimmun Rev. 2020;19(12): 102681.","journal-title":"Autoimmun Rev"},{"key":"1055_CR37","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000781","author":"MC Dalakas","year":"2020","unstructured":"Dalakas MC. Guillain-Barre syndrome: the first documented COVID-19-triggered autoimmune neurologic disease: More to come with myositis in the offing. Neurol Neuroimmunol Neuroinflamm. 2020. https:\/\/doi.org\/10.1212\/NXI.0000000000000781.","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"issue":"7","key":"1055_CR38","doi-asserted-by":"publisher","first-page":"e274","DOI":"10.1097\/INF.0000000000003146","volume":"40","author":"NM Araujo","year":"2021","unstructured":"Araujo NM, Ferreira LC, Dantas DP, Silva DS, Dos Santos CA, Cipolotti R, et al. First report of SARS-CoV-2 detection in cerebrospinal fluid in a child with Guillain-Barre syndrome. Pediatr Infect Dis J. 2021;40(7):e274\u20136.","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"1055_CR39","doi-asserted-by":"publisher","first-page":"6045","DOI":"10.1002\/jmv.27159","volume":"93","author":"F Khan","year":"2021","unstructured":"Khan F, Sharma P, Pandey S, Sharma D, Kumar N, et al. COVID-19-associated Guillain-Barre syndrome: Postinfectious alone or neuroinvasive too? J Med Virol. 2021;93(10):6045\u20139.","journal-title":"J Med Virol"},{"issue":"12","key":"1055_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102983","volume":"20","author":"IA Florian","year":"2021","unstructured":"Florian IA, Lupan I, Sur L, Samasca G, Timi\u0219 TL. To be, or not to be\u2026 Guillain-Barr\u00e9 syndrome. Autoimmun Rev. 2021;20(12): 102983.","journal-title":"Autoimmun Rev"},{"issue":"5","key":"1055_CR41","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awab068","volume":"144","author":"A Vogrig","year":"2021","unstructured":"Vogrig A, Moritz CP, Camdessanch\u00e9 JP, Tholance Y, Antoine JC, Honnorat J, et al. Unclear association between COVID-19 and Guillain-Barr\u00e9 syndrome. Brain. 2021;144(5): e45.","journal-title":"Brain"},{"issue":"1","key":"1055_CR42","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/jns.12482","volume":"27","author":"A Taga","year":"2022","unstructured":"Taga A, Lauria G. COVID-19 and the peripheral nervous system. A 2-year review from the pandemic to the vaccine era. J Peripher Nerv Syst. 2022;27(1):4\u201330.","journal-title":"J Peripher Nerv Syst"},{"issue":"11","key":"1055_CR43","doi-asserted-by":"publisher","first-page":"4093","DOI":"10.1080\/21645515.2021.1954826","volume":"17","author":"R Scendoni","year":"2021","unstructured":"Scendoni R, Petrelli C, Scaloni G, Logullo FO. Electromyoneurography and laboratory findings in a case of Guillain-Barre syndrome after second dose of Pfizer COVID-19 vaccine. Hum Vaccin Immunother. 2021;17(11):4093\u20136.","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"1055_CR44","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/ncn3.12537","volume":"9","author":"J James","year":"2021","unstructured":"James J, Jose J, Gafoor VA, Smita B, Balaram N. Guillain-Barre syndrome following ChAdOx1 nCoV-19 COVID-19 vaccination: a case series. Neurol Clin Neurosci. 2021;9(5):402\u20135.","journal-title":"Neurol Clin Neurosci"},{"key":"1055_CR45","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2021.2219","author":"JE Kim","year":"2022","unstructured":"Kim JE, Park J, Min YG, Hong YH, Song TJ. Associations of Guillain-Barre syndrome with coronavirus disease 2019 vaccination: disproportionality analysis using the World Health Organization pharmacovigilance database. J Peripher Nerv Syst. 2022. https:\/\/doi.org\/10.1001\/jamainternmed.2021.2219.","journal-title":"J Peripher Nerv Syst"},{"issue":"6","key":"1055_CR46","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1177\/1129729820968400","volume":"22","author":"K Woo","year":"2021","unstructured":"Woo K, Pieters H. The patient experience of hemodialysis vascular access decision-making. J Vasc Access. 2021;22(6):911\u20139.","journal-title":"J Vasc Access"},{"key":"1055_CR47","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awac067","author":"RY Keh","year":"2022","unstructured":"Keh RY, Scanlon S, Datta-Nemdharry P, Donegan K, Cavanagh S, Foster M, Skelland D, Palmer J, et al. COVID-19 vaccination and Guillain-Barr\u00e9 syndrome: analyses 1 using the National Immunoglobulin Database. Brain. 2022. https:\/\/doi.org\/10.1093\/brain\/awac067.","journal-title":"Brain"},{"key":"1055_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2021.108818","volume":"230","author":"M Garcia-Grimshaw","year":"2021","unstructured":"Garcia-Grimshaw M, Michel-Chavez A, Vera-Zertuche JM, Galnares-Olalde JA, Hernandez-Vanegas LE, Figueroa-Cucurachi M, et al. Guillain-Barre syndrome is infrequent among recipients of the BNT162b2 mRNA COVID-19 vaccine. Clin Immunol. 2021;230: 108818.","journal-title":"Clin Immunol"},{"key":"1055_CR49","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15504","author":"M Garcia-Grimshaw","year":"2022","unstructured":"Garcia-Grimshaw M, Galnares-Olalde JA, Bello-Chavolla OY, Michel-Chavez A, Cadena-Fernandez A, Briseno-Godinez ME, et al. Incidence of Guillain-Barre syndrome following SARS-CoV-2 immunization: analysis of a nationwide registry of recipients of 81 million doses of seven vaccines. Eur J Neurol. 2022. https:\/\/doi.org\/10.1111\/ene.15504.","journal-title":"Eur J Neurol"},{"issue":"5","key":"1055_CR50","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.3390\/v14051094","volume":"14","author":"HM Hanson","year":"2022","unstructured":"Hanson HM, Willkomm NA, Yang H, Mansky LM. Human retrovirus genomic RNA packaging. Viruses. 2022;14(5):1094.","journal-title":"Viruses"},{"issue":"8","key":"1055_CR51","first-page":"752","volume":"10","author":"M Klugar","year":"2021","unstructured":"Klugar M, Riad A, Mekhemar M, Conrad J, Buchbender M, Howaldt HP, et al. Side effects of mRNA-based and viral vector-based COVID-19 vaccines among german healthcare workers. Biology (Basel). 2021;10(8):752.","journal-title":"Biology (Basel)."},{"issue":"2","key":"1055_CR52","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/mus.27461","volume":"65","author":"LK Loo","year":"2022","unstructured":"Loo LK, Salim O, Liang D, Goel A, Sumangala S, Gowda AS, et al. Acute-onset polyradiculoneuropathy after SARS-CoV2 vaccine in the West and North Midlands, United Kingdom. Muscle Nerve. 2022;65(2):233\u20137.","journal-title":"Muscle Nerve"},{"issue":"2","key":"1055_CR53","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/ana.26143","volume":"90","author":"BV Maramattom","year":"2021","unstructured":"Maramattom BV, Krishnan P, Paul R, Padmanabhan S, Cherukudal Vishnu Nampoothiri S, Syed AA, et al. Guillain-Barre syndrome following ChAdOx1-S\/nCoV-19 vaccine. Ann Neurol. 2021;90(2):312\u20134.","journal-title":"Ann Neurol"},{"issue":"12","key":"1055_CR54","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.3201\/eid2712.211634","volume":"27","author":"SC Shao","year":"2021","unstructured":"Shao SC, Wang CH, Chang KC, Hung MJ, Chen HY, Liao SC. Guillain-Barre syndrome associated with COVID-19 vaccination. Emerg Infect Dis. 2021;27(12):3175\u20138.","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"1055_CR55","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/ana.26258","volume":"91","author":"A Pegat","year":"2022","unstructured":"Pegat A, Vogrig A, Khouri C, Masmoudi K, Vial T, Bernard E. Adenovirus COVID-19 vaccines and guillain-barre syndrome with facial paralysis. Ann Neurol. 2022;91(1):162\u20133.","journal-title":"Ann Neurol"},{"key":"1055_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2022.120330","author":"F Germano","year":"2022","unstructured":"Germano F, Bellucci M, Grisanti S, Beronio A, Grazzini M, Coco E, et al. COVID-19 vaccine-related Guillain-Barr\u00e9 syndrome in the Liguria region of Italy: a multicenter case series. J Neurol Sci. 2022. https:\/\/doi.org\/10.1016\/j.jns.2022.120330.","journal-title":"J Neurol Sci"},{"issue":"11","key":"1055_CR57","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.1111\/ene.15504","volume":"29","author":"M Garc\u00eda-Grimshaw","year":"2022","unstructured":"Garc\u00eda-Grimshaw M, Galnares-Olalde JA, Bello-Chavolla OY, Michel-Ch\u00e1vez A, Cadena-Fern\u00e1ndez A, Brise\u00f1o-God\u00ednez ME, et al. Incidence of Guillain-Barr\u00e9 syndrome following SARS-CoV-2 immunization: analysis of a nationwide registry of recipients of 81 million doses of seven vaccines. Eur J Neurol. 2022;29(11):3368\u201379.","journal-title":"Eur J Neurol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01055-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-023-01055-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01055-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T09:05:25Z","timestamp":1677315925000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-023-01055-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,25]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1055"],"URL":"https:\/\/doi.org\/10.1186\/s40001-023-01055-0","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,25]]},"assertion":[{"value":"14 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"98"}}